-
PHE relaunches "Keep Antibiotics Working" campaign There were an estimated 60,788 antibiotic-resistant infections in England during 2018 - a 9% rise from 2017
-
First-of-its-kind-survey reveals gaps in European healthcare workers’ knowledge and attitudes about antibiotics Healthcare workers from all EU/EEA countries participated in the online study, which included 43 questions
-
General practice antibiotic prescribing rates for respiratory infections vary by illness severity The study used illness severity scores to evaluate the appropriateness of antibiotic prescribing in UK general practice
-
Synthetic antibiotics with novel mechanism of action discovered By disrupting outer membrane synthesis, the novel chimeric antibiotics effectively kill Gram-negative bacteria
-
PHE and WHO partner on new AMR professional learning framework The guide aims to address vast global discrepancies in health worker education and training on antimicrobial resistance
-
Resistance to antibiotics used to treat helicobacter pylori in Europe doubles in 20 years, new study finds Growing H. pylori primary resistance to clarithromycin a global concern that has been recognised by World Health Organization
-
Growing resistance to gonorrhoea first-line antibiotic treatment in UK Between 2017 and 2018, there was a reduction in susceptibility to the current first-line therapy, ceftriaxone.
-
IDWeek 2019 — 2019 guidelines for treating community-acquired pneumonia are updated US societies update their guidelines for treating adult patients.
-
IDWeek 2019 — Meropenem-vaborbactam beats best-available therapy for CRE cure rates Results are from the TANGO II randomized clinical trial.
-
IDWeek 2019 — Resistant Salmonella more common in conventional vs organic poultry meat Salmonella from conventional meat show significantly more antibiotics resistance vs organic poultry samples.
-
Microneedle biosensors accurately detect patient antibiotic levels in real time This small study provides proof-of-concept of real-time, microneedle sensing of penicillin in vivo, with more research planned
-
IDWeek 2019 — Imipenem/relebactam is an option for carbapenem-nonsusceptible infections RESTORE-IMI 1 phase 3 trial results add another option for carbapenem-resistant Gram-negative infections.
-
IDWeek 2019 — 7 days of antibiotics is OK in uncomplicated Gram-negative bacteremia Outcomes are comparable between 7 and 14 days of treatment.
-
IDWeek 2019 — Unnecessary dental prophylaxis can lead to serious antibiotic-related AEs Antibiotic stewardship programs must include dentists.
ANTIBIOTICS
Fully funded by 
Content independently selected
Latest Updates